Synergy between glutathione peroxidase-1 and astrocytic growth factors suppresses free radical generation and protects dopaminergic neurons against 6-hydroxydopamine

Rejuvenation Research

Volumn 14, Issue 2, 2011, Pages 195-204

  Gardaneh, Mossa ^a,b   Gholami, Mostafa ^a   Maghsoudi, Nader ^b  

^a NATIONAL INSTITUTE OF GENETIC ENGINEERING AND BIOTECHNOLOGY   (Iran)

^b SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE 1; HYDROGEN PEROXIDE; LENTIVIRUS VECTOR; NERVE GROWTH FACTOR; OXIDOPAMINE;

ANTIOXIDANT ACTIVITY; ARTICLE; ASTROCYTE; CELL DEATH; CELL GROWTH; CELL LINE; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; DRUG POTENTIATION; EMBRYO; ENZYME ACTIVITY; GENE TRANSFER; HUMAN; HUMAN CELL; HUMAN TISSUE; NEUROBLASTOMA CELL; NEUROPROTECTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; SEQUENCE ANALYSIS; SURVIVAL RATE;

ASTROCYTES; CELL SURVIVAL; CELLS, CULTURED; DOPAMINE; FREE RADICALS; GLUTATHIONE PEROXIDASE; HUMANS; HYDROXYDOPAMINES; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; NEURONS; NEUROPROTECTIVE AGENTS;

LENTIVIRUS; PARKINSONIA;

EID: 79957490305     PISSN: 15491684     EISSN: 15578577     Source Type: Journal    
DOI: 10.1089/rej.2010.1080     Document Type: Article

References (36)

1. Hirsch EC, Faucheux B, Damier P, Mouatt-Prigent A, Agid Y. Neuronal vulnerability in Parkinson's disease. J Neural Transm Suppl 1997;50:79-88. (Pubitemid 27055930)
2. Ziv I, Barzilai A, Offen D, Nardi N, Melamed M. Nigrostriatal neuronal death in Parkinson's disease-a passive or an active genetically-controlled process? J Neural Transm Suppl 1997;49:69-76. (Pubitemid 27351474)
3. Lang AE, Obeso J. Challenges in Parkinson's disease: Restoration of the nigrostriatal dopamine system is not enough. Lancet Neurol 2004;3:309-316. (Pubitemid 38510202)
4. Greenamyre JT, Hastings TG. Parkinson's-Divergent causes, convergent mechanisms. Science 2004;304:1120-1122.
5. Zhou C, Huang Y, Przedborski S. Oxidative stress in Parkinson's disease: A mechanism of pathogenic and therapeutic significance. Ann NY Acad Sci 2008;1147:93-104.
6. Halliwell B. Oxidative stress and neurodegeneration: Where are we now? J Neurochem. 2006;97:1634-1658. (Pubitemid 43873658)
7. Jenner P, Dexter DT, Sian J, Schapira AHV, Marsden CD. Oxidative stress as a cause of nigral cell death in Parkinson's disease and incidental Lewy body disease. Ann Neurol 1992;32:S82-S87.
8. Sofic E, Lange KW, Jellinger K, Riederer P. Reduced and oxidized glutathione in the substantia nigra of patients with Parkinson's disease. Neurosci Lett 1992;142:128-130.
9. Heales SJR, Davies SEC, Bates TE, Clark JB. Depletion of brain glutathione is accompanied by impaired mitochondrial function and decreased N-acetyl aspartate concentration. Neurochem Res 1995;20:31-38.
10. Wullner U, Loschmann PA, Schulz JB, Schmid A, Dringen R, Eblen F, Turski L, and Klockgether T. Glutathione depletion potentiates MPTP and MPP\+ toxicity in nigral dopaminergic neurones. Neuroreport 1996;7:921-923. (Pubitemid 26167978)
11. Halliwell B. Biologically relevant metal ion-dependent hydroxyl radical generation. FEBS Lett 1992;307:108-112.
12. Cheng W, Fu YX, Porres JM, Ross DA, Lei XG. Seleniumdependent cellular glutathione peroxidase protects mice against a pro-oxidant-induced oxidation of NADPH, NADH, lipids, and protein. FASEB J 1999;13:1467-1475. (Pubitemid 29382514)
13. Lei XG, Cheng W-H, McClung JP. Metabolic regulation and function of glutathione peroxidase-1. Annu Rev Nutr 2007;27:41-61. (Pubitemid 351373347)
14. Lindenau J, Noack H, Asayama K, Wolf G. Enhanced cellular glutathione peroxidase immunoreactivity in activated astrocytes and in microglia during excitotoxin induced neurodegeneration. Glia 1998;24:252-256. (Pubitemid 28404003)
15. Power JH, Blumbergs PC. Cellular glutathione peroxidase in human brain: cellular distribution, and its potential role in the degradation of Lewy bodies in Parkinson's disease and dementia with Lewy bodies. Acta Neuropathol 2009;117:63-73.
16. Damier P, Hirsch EC, Zhang P, Agid Y, Javoy-Agid F. Glutathione peroxidase, glial cells and Parkinson's disease. Neuroscience 1993;52:1-6. (Pubitemid 23026600)
17. Mirault ME, Tremblay A, Beaudoin N, Tremblay M. Overexpression of seleno-glutathione peroxidase by gene transfer enhances the resistance of T47D human breast cells to clastogenic oxidants. J Biol Chem 1991;266:20752-10760.
18. Taylor SD, Davenport LD, Speranza MJ, Mullenbach GT, Lynch RE. Glutathione peroxidase protects cultured mammalian cells from the toxicity of adriamycin and paraquat. Arch. Biochem. Biophys 1993;305:600-605. (Pubitemid 23282952)
19. Cheng WH, Ho YS, Valentine BA, Ross DA, Combs GFJ, Lei XG. Cellular glutathione peroxidase is the mediator of body selenium to protect against paraquat lethality in transgenic mice. J Nutr 1998;128:1070-1076. (Pubitemid 28317668)
20. Ridet JL, Bensadoun JC, Déglon N, Aebischer P, Zurn AD. Lentivirus-mediated expression of glutathione peroxidase: Neuroprotection in murine models of Parkinson's disease. Neurobiol Dis 2006;21:29-34. (Pubitemid 41817302)
21. Bensadoun JC, Mirochnitchenko O, Inouye M, Aebischer P, Zurn AD. Attenuation of 6-OHDA-induced neurotoxicity in glutathione peroxidase transgenic mice. Eur J Neurosci 1998;10:3231-3236. (Pubitemid 29070619)
22. Thiruchelvam M, Prokopenko O, Cory-Slechta DA, Buckley B, Mirochnitchenko O. Overexpression of superoxide dismutase or glutathione peroxidase protects against the paraquat\+maneb-induced Parkinson disease phenotype. J Biol Chem 2005;280:22530-22539. (Pubitemid 40827911)
23. Klivenyi P, Andreassen OA, Ferrante RJ, Dedeoglu A, Mueller G, Lancelot E, Bogdanov M, Andersen JK, Jiang D, Beal MF. Mice deficient in cellular glutathione peroxidase show increased vulnerability to malonate, 3-nitropropionic acid, and 1-methyl-4- phenyl-1,2,5,6-tetrahydropyridine. J Neurosci 2000;20:1-7. (Pubitemid 30220485)
24. Zhang J, Graham DG, Montine TJ, Ho YS. Enhanced Nmethyl- 1,2,3,6-tetrahydropyridine toxicity in mice deficient in CuZn-superoxide dismutase or glutathione peroxidase. J Neuropathol Exp Neurol 2000;59:53-61. (Pubitemid 30069225)
25. Sandhu JK, Gardaneh M, Iwasiow R, Lanthier P, Gangaraju S, Ribecco-Lutkiewicz M, Tremblay R, Kiuchi K, Sikorska M. Astrocyte-secreted GDNF and glutathione antioxidant system protect neurons against 6-OHDA cytotoxicity. Neurobiol Dis 2009;33:405-414.
26. Pluta K, Luce ML, Bao L, Agha-Mohammadi S, Reiser J. Tight control of transgene expression by lentivirus vectors containing second-generation tetracycline-responsive promoters. J Gene Med 2005;7:803-817. (Pubitemid 40872866)
27. Weiss N, Zhang YY, Heydrick S, Bierl C, Loscalzo J. Overexpression of cellular glutathione peroxidase rescues homocyst(e)ine-induced endothelial dysfunction. Proc Natl Acad Sci USA 2001;98:12503-12508. (Pubitemid 33019975)
28. Moscow JA, Morrow CS, He R, Mullenbachalln GT, Cowan KH. Structure and function of the 50-flanking sequence of the human cytosolic selenium-dependent glutathione peroxidase gene (hgpxl). J Biol Chem 1992;267: 5949-5958.
29. St. Clair DK, Chow CK. Glutathione peroxidase: Activity and steady-state level of mRNA. In: Punchard NA, Kelly FJ (eds.). Free Radicals. IRL Press, Oxford, 1996, pp 227-240.
30. Browne RW, Armstrong D Reduced glutathione and glutathione disulfide. In: Armstrong D (ed.). Free Radical and Anti-oxidant Protocols. Humana Press, Totowa N, 1998, pp 347-352.
31. Tariq M, Ahmad Khan H, Al Moutaery K, Al Deeb S. Protective effect of quinacrine on striatal dopamine levels in 6- OHDA and MPTP models of Parkinsonism in rodents. Brain Res Bullet 2001;54:77-82. (Pubitemid 32156918)
32. Garia JC, Remires D, Leiva A, Gonzalez R. Depletion of brain glutathione potentiates the effect of 6-hydroxydopamine in a rat model of parkinson's disease J Mol Neurosci 2000;14: 147-153. (Pubitemid 30660804)
33. Dringen R, Hirrlinger J. Glutathione pathways in the brain. Biol Chem 2003;384:505-516. (Pubitemid 36609167)
34. Chao CC, Lee EHY. Neuroprotective mechanism of glial cell line-derived neurotrophic factor on dopamine neurons: role of anti-oxidation. Neuropharmachology 1999;38:913-916. (Pubitemid 29187351)
35. Gardaneh M, Shojaei S, Saafi R, Panahi P, Gholami M. Synergy between glial cell line-derived neuotrophic factor and glutathione peroxidase-1 maximizes protection of dopaminergic neurons against parkinsonian toxicity (abstract). Annual Meeting of Society for Neuroscience, Nov 14-17, 2010, San Diego, CA.
36. Gardaneh M, O'Malley K. Rat tyrosine hydroxylase promoter directs tetracycline-inducible foreign gene expression in dopaminergic cell types. Mol Brain Res 2004;126: 173-180. (Pubitemid 38891839)